Production (Stage)
NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 39.00K | 44.30K | 44.40K | 44.50K | 26.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.00K | 44.30K | 44.40K | 52.10K | 28.00K |
| Operating Income | -39.00K | -44.30K | -44.40K | -52.10K | -28.00K |
| Income Before Tax | -97.20K | 407.40K | -41.70K | -61.10K | -41.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -97.20K | 407.40K | -41.70K | -61.10K | -41.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.20K | 407.40K | -41.70K | -61.10K | -41.30K |
| EBIT | -39.00K | -44.30K | -44.40K | -52.10K | -28.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.04 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.04 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
| Average Diluted Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |